Q-002

N/A

Report date: 2025/01/26 19:29:14

NME

Base Information

Drug NameQ-002

Drug Alias NameQ-002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTransient receptor potential cation channel subfamily V member 6 modulators

TargetsTransient receptor potential cation channel subfamily V member 6

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniquest Pty Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A